the American Journal of Psychiatry
PHILADELPHIA -- November 16, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology.
PHILADELPHIA -- November 16, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology.
HONOLULU - October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended Release Tablets, a
PHILADEPHIA -- July 22, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in chi
DALLAS - May 13, 2009 - One reason antidepressant medication treatments do not work as well in real life as they do in clinical studies could be the limited type of study participants selected, researchers at UT Southwestern Medical Center have found.
PITTSBURGH, April 28 - Findings from clinical studies used to gain Food and Drug Administration approval of common antidepressants are not applicable to most patients with depression, according to a report led by the University of Pittsburgh Graduate School of Public Health.
Marijuana is not a “gateway” drug that predicts or eventually leads to substance abuse, suggests a 12-year University of Pittsburgh study.
Unlike younger recreational gamblers who show high rates of alcohol use and abuse, depression, bankruptcy and incarceration, there appears to be an association between recreational gambling and good health among elderly persons, according to a Yale study in the American Journal of Psychiatry. Rani Desai, associate professor of psychiatry at Yale School of Medicine, said it is not clear why there is a positive correlation of good health in moderate gamblers 65 years and older. It may be, she suggested, that healthier adults who are able to gamble are simply healthier to begin with. There may be other reasons as well, Desai said.
Researchers say they have strongly linked a specific gene with autism. While earlier studies have found rare genetic mutations in single families, a study published in the April issue of the American Journal of Psychiatry is the first to identify a gene that increases susceptibility to autism in a broad population. Approximately 1 in 1,000 people have autism or autistic disorder. It appears to be the most highly genetic of all psychiatric disorders. If a family with one autistic child has another child the chance that this child would be autistic is 50 to 100 times more likely to than would be expected by chance.
